Capricor Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Capricor Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Capricor Therapeutics Inc
Rating: 0.84875
Author: Trendlyne DVM scores

about

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in mu...

6.26 0.01 (0.16%)

73.25% Fall from 52W High

1.0M

XNAS Volume

XNAS 28 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

13.5 / 100

Technically Bearish

20.5 / 100

1Yr Price target upside is 229%

10 analysts

Capricor Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Capricor Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in mu...

73.25% Fall from 52W High

SWOT Analysis

Capricor Therapeutics Inc Live Price Chart